The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Mechanisms of uremic erythrocyte‐induced adhesion of human monocytes to cultured endothelial cells
Abstract
In end‐stage renal disease (ESRD) endothelium may represent a key target for the action of circulating elements, such as modified erythrocytes (RBC) and/or plasmatic factors, that may facilitate inflammation and the vasculopathy associated with uremia. We have previously demonstrated that phosphatidylserine (PS) exposure on the surface of RBC from ESRD patients increases RBC‐human umbilical vein endothelial cell (HUVEC) interactions and causes decreased nitric oxide (NO) production. We postulated that, besides the pro‐inflammatory effects due to decreased NO bio‐availability, enhanced ESRD‐RBC‐HUVEC interactions might directly stimulate pro‐inflammatory pathways leading to increased vascular adhesion molecule expression. ESRD‐RBC‐endothelial cell interactions induced a time‐dependent up‐regulation of VCAM‐1 and ICAM‐1 (measured by Western blot (WB) and real‐time PCR), associated with mitogen‐activated protein kinase (MAPK) activation and impairment of the Akt/endothelial nitric oxide synthase (eNOS) signaling cascade, measured by WB. In reconstitution experiments, normal RBC incubated with uremic plasma showed increased PS exposure and significantly increased VCAM‐1 and ICAM‐1 mRNA levels when incubated on HUVEC. Interestingly, ESRD‐RBC induced increased expression of adhesion molecules was prevented by Annexin‐V (AnV, able to mask PS on RBC surface), anti‐integrin‐αvβ3, anti‐thrombospondin‐1 (TSP‐1), and PD98059 (a selective inhibitor of MAPK phosphorylation). Moreover, AnV reversed the ESRD‐RBC effects on MAPK and Akt/eNOS signaling pathways. Our data demonstrate that, possibly via a direct interaction with the endothelial thrombospondin‐(αvβ3) integrin complex, ESRD‐RBC‐HUVEC adhesion induces a vascular inflammatory phenotype. Thus, intervention targeting ESRD‐RBC increased adhesion to endothelium and/or MAPK and Akt/eNOS pathways may have the potential to prevent vascular lesions under uremic conditions. J. Cell. Physiol. 213:699–709. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease
Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J., Safar, M. E., & London, G. M. (1999) · Circulation · doi:10.1161/01.cir.99.18.2434 · Cited by 2,138
NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727 · cited 1×
“All these factors could enhance nuclear factor-kB (NF-kB) activation leading to up-regulation of vascular adhesion molecules (Singh et al., 2000; Collins and Cybulsky, 2001).”
BackgroundRole of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation
KOFLER, S., NICKEL, T., & WEIS, M. (2005) · Clinical Science · doi:10.1042/cs20040174 · Cited by 353
The Apolipoprotein E Knockout Mouse: A Model Documenting Accelerated Atherogenesis In Uremia
Buzello, M., Törnig, J., Faulhaber, J., Ehmke, H., Ritz, E., & Amann, K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000045048.71975.fc · Cited by 167
Cited by
Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease
Silverstein, D. M. (2009) · Pediatric Nephrology · doi:10.1007/s00467-008-1046-0 · Cited by 300
Ceramide in Suicidal Death of Erythrocytes
Lang, F., Gulbins, E., Lang, P. A., Zappulla, D., & Föller, M. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315102 · Cited by 259
Metadata
- Authors
- Pandolfi, A., Di Pietro, N., Sirolli, V., Giardinelli, A., Di Silvestre, S., Amoroso, L., Di Tomo, P., Capani, F., Consoli, A., & Bonomini, M.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2007-05-21
- Volume
- 213
- Issue
- 3
- Pages
- 699-709
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2089281127
- Cited by
- 185
- References
- 4
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.